Tackling Drug-Resistant Tuberculosis: A Structural Insight into Efflux Pumps
As part of the ISIDORe project, Joana Santos from i3S (Portugal) collaborated with Instruct-ERIC’s Membrane Protein Production Lab at Diamond...
ISIDORe success stories
Strengthening Community Engagement in the Fight Against Tickborne Diseases
Through ISIDORe, researchers from the Institut Pasteur’s Anthropology and Ecology of Disease Emergence unit accessed the MORU Community Engagement...
Adoptive Memory T Cell Therapy Shows Promise in Phase 2 COVID-19 Clinical Trial
Supported by ISIDORe, a phase 2 multicenter clinical trial led by IdiPAZ-FIBHULP (Spain) in collaboration with Oslo University Hospital (Norway)...
Addressing Ethical Challenges in Sharing Qualitative Research Data During Pandemics
The COVID-19 pandemic has brought renewed attention to the importance of open data sharing to improve epidemic preparedness and response. However,...
Combatting Leishmaniasis: Advancing Sand Fly Monitoring and Resistance Managementg
A groundbreaking study in PLOS Neglected Tropical Diseases sheds light on innovative tools for monitoring sand flies, the primary vectors of...
Improving Epidemic Response through Social Science Training in Africa
This project aimed to enhance the ability of healthcare professionals in Africa to respond more effectively to epidemics by incorporating social and...
SARS-CoV-2 Therapeutics Development
Led by researcher Kurt Zatloukal, focused on developing therapeutics to block SARS-CoV-2 infections and replication, particularly by inhibiting the...
Nasal Spray Formulation of LTX-109 as a Therapeutic for SARS-CoV-2 and Influenza
Pharma Holdings, led by Johnny I. Ryvoll in Norway, sought regulatory advice from EATRIS regarding the development of a nasal spray formulation for...
Regulatory Advice for the Development of a Virus-Like Particle Vaccine Platform
Alexander Jerman from Sferogen, a pre-clinical stage biotech company in Slovenia, sought regulatory advice regarding the development of their...
NMR Binding Studies of Antiviral Compounds Targeting SARS-CoV-2
Led by Prof. Amadeu Llebaria from Barcelona, Spain, this project aimed to explore the binding properties of two families of antiviral compounds...